Drug Shortage Report for AURO-LOSARTAN
| Report ID | 68135 |
| Drug Identification Number | 02403331 |
| Brand name | AURO-LOSARTAN |
| Common or Proper name | Losartan Potassium |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 50.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 & 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-29 |
| Estimated end date | Unknown |
| Actual end date | 2023-11-10 |
| Shortage status | Resolved |
| Updated date | 2023-11-11 |
| Company comments | Auro - Losartan 50 mg (100's) is available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.